Literature DB >> 7476303

Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment.

Z Laron1, Y Avitzur, B Klinger.   

Abstract

Among 43 patients with Laron syndrome followed in our clinic, we were able to study the carbohydrate metabolism from infancy into adult age in 30 patients. During infancy, fasting blood glucose levels were in the hypoglycemic range (mean +/- SD, 3.5 +/- 1.2 mmol/L) and increased at the end of a delayed puberty to 4.6 +/- 0.6 mmol/L. Fasting plasma insulin was higher than expected for concomitant glucose levels, and several of the 20 patients who underwent an oral glucose tolerance test (OGTT) had glucose intolerance and relatively high insulin levels. In adult patients, insulinopenia developed and one 38-year-old patient developed non-insulin-dependent diabetes mellitus (NIDDM) with subsequent need for insulin therapy. Continuous insulin-like growth factor-I (IGF-I) treatment of a pubertal patient with glucose intolerance and hyperinsulinemia normalized both responses. In conclusion, long-term IGF-I deficiency leads to insulin resistance, which is reversed by exogenous IGF-I administration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476303     DOI: 10.1016/0026-0495(95)90231-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  A 90-day safety study of genetically modified rice expressing rhIGF-1 protein in C57BL/6J rats.

Authors:  Maoxue Tang; Tingting Xie; Wenke Cheng; Lili Qian; Shulin Yang; Daichang Yang; Wentao Cui; Kui Li
Journal:  Transgenic Res       Date:  2011-09-11       Impact factor: 2.788

Review 2.  Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

Authors:  Edward O List; Lucila Sackmann-Sala; Darlene E Berryman; Kevin Funk; Bruce Kelder; Elahu S Gosney; Shigeru Okada; Juan Ding; Diana Cruz-Topete; John J Kopchick
Journal:  Endocr Rev       Date:  2010-12-01       Impact factor: 19.871

Review 3.  The GH/IGF-1 axis in ageing and longevity.

Authors:  Riia K Junnila; John J Kopchick; Edward O List; Darlene E Berryman; John W Murrey
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

4.  The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.

Authors:  David R Clemmons
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

5.  Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density.

Authors:  Catalina Cabrera-Salcedo; Tomoyuki Mizuno; Leah Tyzinski; Melissa Andrew; Alexander A Vinks; Jan Frystyk; Halley Wasserman; Catherine M Gordon; Vivian Hwa; Philippe Backeljauw; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

6.  Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.

Authors:  Taísa A R Vicente; Ivina E S Rocha; Roberto Salvatori; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Viviane C Campos; Elenilde G Santos; Rachel D C Araújo Diniz; Eugênia H O Valença; Carlos C Epitácio-Pereira; Mario C P Oliveira; Andrea Mari; Manuel H Aguiar-Oliveira
Journal:  Endocr Connect       Date:  2013-06-15       Impact factor: 3.335

7.  Expression of brain-derived neurotrophic factor, IGF-1 and cortisol elicited by regular aerobic exercise in adolescents.

Authors:  Yong Kyun Jeon; Chang Ho Ha
Journal:  J Phys Ther Sci       Date:  2015-03-31

8.  Primary growth hormone insensitivity and psychomotor delay.

Authors:  Inma Castilla-Cortazar; Julieta Rodríguez De Ita; Gabriel A Aguirre; Joel Rodríguez-Rivera; Mariano García-Magariño; Irene Martín-Estal; Óscar Flores-Caloca; Carlos Diaz-Olachea
Journal:  Clin Case Rep       Date:  2018-01-18

9.  Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.

Authors:  Danilo Fintini; Claudia Brufani; Marco Cappa
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

Review 10.  Laron syndrome - A historical perspective.

Authors:  Zvi Laron; Haim Werner
Journal:  Rev Endocr Metab Disord       Date:  2020-09-22       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.